History of the Development of Atrial Septal Occlusion Devices
1Division of Cardiothoracic Surgery, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA.
Current Interventional Cardiology Reports
|November 30, 2000
Abstract:
In this review, historical developments related to transcatheter occlusion of atrial septal defects (ASDs) are discussed. Since the initial description by King of transvenous closure of secundum ASDs in the mid 1970s, a variety of double disc and single disc devices have been designed and tested in animal models and human subjects. Feasibility, safety, and effectiveness have been demonstrated. Further developments are likely to result in the availability of device closure technology to all patient subsets.
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...